How Automation Can Facilitate Annex-1 Compliance in Final Filtration
WEBINAR
In this webinar, you will learn:
- How Annex-1 requirements impact Final Filtration operations, focusing on PUPSIT implementation
- Why Single-Use assemblies can reduce patient and business risks
- How an automated system can optimize product recovery and your facility layout
Final sterilizing filtration is the last unit operation assuring the sterility of medicinal products for human use. Single-Use platforms are increasingly adopted in all bioprocessing which requires a holistic approach to assure sterility of the system that encompasses both filters and components. EU GMP Annex-1 lays out the requirements to perform integrity tests on the sterilized filter assembly before (PUPSIT) and after use and highlights the increased amount of complex manual operations that needs to be carefully assessed.
This webinar focuses on aspects of new products and system design that help biomanufacturing customers meet the regulatory requirements and become an essential part of the contamination control strategy. Our offering maximizes product recovery at minimized operator risk and equips your drug product facilities with tailored process intensification technologies.
Speakers

Tobias Weitzel
Merck
Senior Strategic Product Manager - PUPSIT
Tobias is a Senior Strategic Product Manager in the Single-Use Integrated Platform Solutions business. His main focus is on business development and scale-up for the Mobius iPUPSIT® filtration system while working on continuous improvements and new additions to our Single-Use systems portfolio.
He joined our company in 2016 and has held different strategy development positions for our Process Solutions business as well as across our business Sectors Healthcare, Life Science and Electronics covering multiple technology and sustainability projects. Tobias holds a M.Sc. in International Management from the Nova School of Business and Economics in Lisbon (Portugal).

Mehdi Boukami
Merck
Field Marketing Specialist - Single-Use Technologies
Mehdi Boukami holds a Master’s degree in Biomolecular Engineering from the Bordeaux National School of Biomolecule Technology. He joined our company in 2008 and held multiple customer facing positions involving filtration & single use business.
In his role he investigates the market needs and trends of single-use technologies with a focus on critical application such as final filtration & filling, and other key topics such as quality requirements and supply.
Pharma and biopharma manufacturing
- Final Sterile Filtration
Duration:
Language:English
Session 1:presented January 22, 2026
To continue reading please sign in or create an account.
Don't Have An Account?